bioRxivNeurosciencePreprint
Programmable self-assembling system to model intracellular protein aggregation and decode neurodegenerative diseases
Yujie FaniD, Jonathan D. HoangiD, Chelsie SteeleiD, Yochana BenchetritiD, Sayan DuttaiD, Gerard Michael CoughliniD, Nathan ApplingiD, Xiaozhe DingiD, Changfan LiniD, Zhe QuiD, Elisha D. Mackey, Viviana GradinaruiD
- Citations
- 1
Abstract
Pathological protein aggregation is a conserved feature of neurodegenerative diseases. However, slow progression, aggregates heterogeneity and selective vulnerability make it challenging to model diseases and dissect mechanisms. Here, we present a genetically-encoded, modular platform of self-assembling protein that enables inducible, tunable and cell-type-specific formation of intracellular protein aggregates. We engineered self-assembling variants of -synuclein (SAS), Tau, and TDP-43, recapitulating hallmarks of Parkinsons disease, Alzheimers disease, and ALS, respectively. SAS formed Lewy body-like inclusions, nucleated endogenous -synuclein, triggered neuroinflammation and neurite degeneration; Self-assembling-Tau induced tangles formation, extracellular A{beta} and severe neurodegeneration; Self-assembling-TDP caused TDP-43 mislocalization and cytoplasmic inclusions with mild degeneration. Notably, the system revealed disease-specific aggregate-organelle interactions. In vivo, systemic or dopamine neuron-targeted delivery of SAS induced progressive motor deficits, dopaminergic neuron loss, and microglial activation. Our self-assembling system robustly mirrors histological, transcriptional, and behavioral features of human disease, providing a powerful platform to dissect mechanisms and accelerate therapeutic development. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=189 HEIGHT=200 SRC="FIGDIR/small/641009v2_ufig1.gif" ALT="Figure 1"> View larger version (71K): org.highwire.dtl.DTLVardef@1906bb2org.highwire.dtl.DTLVardef@8e8141org.highwire.dtl.DTLVardef@1c7e62dorg.highwire.dtl.DTLVardef@d8c05a_HPS_FORMAT_FIGEXP M_FIG C_FIG
- assay: protein structure
- research focus: protein design
- research focus: drug response / drug discovery
- research focus: benchmarking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Targeted degradation of pathologic tau aggregates via AUTOTAC ameliorates tauopathy
Jihoon Lee, Su Kim, … Yong Tae Kwon·bioRxiv·Sep 10, 2025
- Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization
Antonio Dominguez‐Meijide, Eftychia Vasili, … Tiago F. Outeiro·Scientific ReportsPeer-reviewed·Jul 30, 2020
- Targeted degradation of α-synuclein prevents PFF-induced aggregation
Bill Carton, Géraldine Gelders, … Gopal P. Sapkota·bioRxiv·Apr 15, 2025
- Leveraging Supramolecular Polymers to Induce the Targeted Protein Degradation of α-Synuclein
Windfield S. Swetman, Malay Mondal, … Tristan D. Clemons·bioRxiv·Jul 23, 2026
- An automated workflow for quantifying the formation of synuclein aggregates in human dopaminergic neurons
Chanshuai Han, Emmanuelle Nguyen, … Thomas M. Durcan·MethodsPeer-reviewed·Jun 15, 2026
- Tbc1d15 knockdown in vivo alleviates α-synuclein-induced neurotoxicity by promoting autophagy.
Farah H. Siddiqi, Nakul Ravi Raval, … Patrick Ejlerskov·bioRxiv·Oct 1, 2024